封面
市場調查報告書
商品編碼
1198212

呼吸監測市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Respiratory Monitoring Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內,呼吸監測市場預計將以 9.5% 的複合年增長率增長。

COVID-19 的爆發對呼吸監測市場產生了重大影響。 由於需要連續呼吸監測的 COVID-19 病例增加,在 COVID-19 流行期間,對呼吸監測設備的需求顯著增長。 此外,根據 2021 年 6 月發表在 MDPI 期刊上的一項研究,較低的二氧化碳水平與 COVID-19 患者的死亡風險增加有關。 因此,二氧化碳圖分析可以成為跟蹤 COVID-19 患者 CO2 水平的有用方法。 預計這些好處將推動市場超越大流行。 此外,根據美敦力 2022 年年度報告,COVID-19 已經並將繼續對呼吸監測的增長產生負面影響。 它還表示,在 2022 財年用於 NICU 的 Nellcor 脈搏血氧飽和度傳感器和 SonarMed 氣道監測系統的推動下,呼吸監測將繼續被接受和增長。 因此,上述因素表明,大流行影響了各種呼吸監測設備的日益普及,從而推動了增長。

由於呼吸道疾病增多、吸煙率高以及呼吸監測市場先進技術的開發,預計呼吸監測市場將出現快速增長。 例如,據世界衛生組織稱,到 2021 年,慢性呼吸道疾病將影響全球超過 10 億人。 此外,根據 Lung India 截至 2022 年 8 月的數據,2021 年,印度兒童哮喘的患病率約為 18.2%。 此外,根據國際呼吸學會論壇 2022 年報告,估計約有 2 億人患有慢性阻塞性肺病,2.62 億人患有哮喘。 此外,根據 FDA 和 CDC 於 2022 年 11 月發布的 2022 年全國青年煙草調查的聯邦數據,超過十分之一的中學生(308 萬)將在 2022 年 10 月至 2022 年 11 月期間使用煙草產品。好像有16.5%的高中生和4.5%的初中生用過無菸。 如此高的呼吸系統疾病患病率和高吸煙率預計將增加對呼吸監測的需求,並最終在預測期內推動市場。

此外,主要市場參與者推出的各種產品支持預測期內的市場擴張。 例如,2021 年 3 月,Vyaire Medical 在英國推出了創新的遠程 Aiocare 移動肺量計。 該設備有助於快速診斷肺部疾病,例如哮喘和慢性阻塞性肺病,準確度可與醫院級肺活量計相媲美。 此類產品的推出有望在預測期內推動呼吸監測市場的增長。 此外,製藥公司的各種舉措正在推動市場的增長。 例如,2021 年 11 月,Smile Train 和 Lifebox 發布了二氧化碳圖設備的徵求建議書 (RFP),以幫助 Smile Train 的合作醫院為兒童提供完整和安全的裂傷護理。 預計此類公司的市場發展將在預測期內帶動市場。

然而,報銷問題和監控設備的高價格預計會抑制市場增長。

呼吸監測市場趨勢

預計在預測期內肺活量計部分將實現高增長

肺活量計是一種測量進出肺部的空氣量的設備。 使用肺活量計測量進出肺部的空氣。 在肺活量圖上可以看到異常的阻塞性抑制通氣模式。 由於 COPD、哮喘和肺結核等慢性呼吸系統疾病的日益流行以及肺活量計的技術改進,預計該領域將會增長。 例如,根據 2021 年 7 月發表在 MDPI Diagnostics 上的一項研究,COPD 在澳大利亞為 14.5%,在中國為 4.4%-16.7%,在印度尼西亞為 5.6%,COPD(哮喘根除後)在日本為 8.6%,預計韓國13.4%,馬來西亞4.7%,台灣5.4%-6.1%,泰國3.7%-6.8%,菲律賓3.5%-20.8%,越南6%。 這樣,隨著呼吸系統疾病的增加,對監測的需求有望增加,這有望推動該領域的增長。

此外,為了保持市場競爭力,企業正在推動先進技術的開發、新產品的推出以及與市場參與者的戰略聯盟。 例如,Cipla Limited 在 2021 年 11 月的世界慢性阻塞性肺病日推出了印度首款基於 pneumotouch 的手持式無線肺量計“Spirofy”。 通過此次發布,該公司打算徹底改變阻塞性氣道疾病( OAD )診斷,以符合其加強其在印度肺部領導者地位的雄心。 預計此類產品的推出將在預測期內推動細分市場的增長。

因此,由於上述因素,預計肺活量計領域在未來幾年將呈現顯著增長。

預計在預測期內北美將主導呼吸監測市場

北美在呼吸監測市場佔據主導地位,這主要是由於呼吸系統疾病患病率上升。 此外,該國的人均醫療保健支出正在增加,並且由於失業率下降,預計在預測期內會增加。 根據美國哮喘與過敏基金會的數據,截至 2021 年 4 月,美國每年將有超過 2000 萬 18 歲及以上的人患有哮喘病。 因此,該國出現此類症狀的頻率表明對呼吸設備的穩定需求,導緻美國研究市場的增長。 根據 2022 年 7 月發表在 Pulmonary Therapy 上的一項研究,最常見的呼吸道症狀是排痰性咳嗽和呼吸急促後影響 17% 的美國成年人。 因此,隨著呼吸系統疾病負擔的增加,預計在預測期內對呼吸監測設備的需求將增加,從而推動市場增長。

此外,該地區市場參與者對先進技術的開發也為市場的擴張提供了支持。 例如,2022 年 3 月,總部位於美國的呼吸保健技術公司 Respira Labs 推出了一款由人工智能驅動的可穿戴肺部監測儀,該監測儀使用聲共振來評估肺功能並識別肺氣量的波動。發布了“Sylvee”。 我們支持慢性阻塞性肺病 (COPD)、哮喘和 COVID-19 的早期檢測和治療。 此外,2022 年 3 月,呼吸健康管理公司 Respiri 在美國密歇根州的一家兒童醫院啟動了首個報銷遠程患者監護 (RPM) 試點項目。 預計市場參與者的這種努力將在預測期內推動市場增長。

呼吸監測市場競爭對手分析

由於公司在全球和區域開展業務,呼吸監測市場不景氣。 競爭格局包括知名國際公司和本地公司分析。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 呼吸道疾病增加
    • 吸煙率高
    • 先進技術的開發
  • 市場製約因素
    • 報銷問題
    • 監控設備價格高
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分(基於價值的市場規模 - 百萬美元)

  • 按設備類型
    • 肺量計
    • 峰值流量計
    • 睡眠測試設備
    • 氣體分析儀
    • 脈搏血氧計
    • 二氧化碳圖
    • 其他設備
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Airsep Corporation
    • Medtronic(Covidien)
    • Draegerwerk
    • GE Healthcare
    • Hamilton Medical
    • Getinge Inc.
    • Philips Healthcare
    • Resmed
    • Siemens Healthcare
    • Vyaire Medical, Inc.
    • Nihon Kohden Corporation
    • Smiths Medical

第7章 市場機會與今後動向

簡介目錄
Product Code: 52772

The respiratory monitoring market is expected to register a CAGR of 9.5% over the forecast period.

The outbreak of COVID-19 impacted the respiratory monitoring market significantly. The demand for respiratory monitoring devices has witnessed significant growth during the COVID-19 pandemic due to the increasing number of COVID-19 cases which require continuous respiratory monitoring. Additionally, as per the study published in MDPI Journal in June 2021, lower CO2 levels were associated with an increased risk of death in COVID-19 patients. Hence, analysis of the capnogram can therefore be a useful method for tracking CO2 levels in COVID-19 patients. Such an advantage is expected to drive the market over the pandemic. Furthermore, as per Medtronic's 2022 annual report, COVID-19 is having, and will continue to have, an adverse impact on increasing respiratory monitoring. It also stated that there is a continuous acceptance and growth in respiratory monitoring, led by the Nellcor pulse oximetry sensors and SonarMed Airway Monitoring System for the NICU in the fiscal year 2022. Hence, the above-mentioned factor indicated the impact of the pandemic on the rising adoption of various respiratory monitoring devices, thus driving growth.

The respiratory monitoring market will show rapid growth due to the rise in the number of respiratory diseases, the high prevalence of tobacco smoking, and the development of advanced technologies in respiratory monitoring market. For instance, as per WHO, in 2021, chronic respiratory diseases affect more than one billion people globally. Also, as per the data from Lung India as of August 2022, the prevalence of asthma among Indian children was around 18.2%, in 2021. Furthermore, according to the Forum of International Respiratory Societies report 2022, approximately 200 million people are estimated to have COPD, and 262 million people are affected by Asthma. Additionally, in November 2022, FDA and CDC released federal data from the 2022 National Youth Tobacco Survey which showed that in 2022, more than 1 in 10 middle and high school students (3.08 million) had used a tobacco product from October to November 2022 including 16.5% of high school and 4.5% of middle school students out of which 2.4% were smokeless. Such a high prevalence of respiratory disease and the high prevalence of tobacco smoking are expected to increase the demand for respiratory monitoring, eventually driving the market over the forecast period.

Moreover, various product launches by the key market players support the market expansion over the forecast period. For instance, in March 2021, Vyaire Medical launched its innovative remote Aiocare mobile spirometer in the United Kingdom. The device helps promptly diagnose pulmonary diseases such as asthma and COPD as accurately as hospital-grade spirometers. Such product launches are expected to propel the growth of the respiratory monitoring devices market over the forecast period. Additionally, various initiatives taken by the pharmaceutical players propel the market's growth. For instance, in November 2021, Smile Train and Lifebox issued a Request for Proposals (RFP) for a capnography device to help Smile Train partner hospitals provide complete, safe cleft care for children. Such company developments are expected to drive the market over the forecast period.

However, reimbursement concerns and the high price of the monitoring devices are the factors expected to restrain the market growth.

Respiratory Monitoring Market Trends

Spirometer Segment is Expected to Witness High Growth Over the Forecast Period

A spirometer is a device that measures the amount of air that is inspired and expelled by the lungs. The passage of air in and out of the lungs is measured with a spirometer. Obstructive and restrictive aberrant ventilation patterns can be identified by the spirogram. The segment is expected to grow due to the increasing prevalence of chronic respiratory diseases such as COPD, Asthma, TB, etc., and technological improvements in spirometers. For instance, according to the study published in MDPI Diagnostics in July 2021, COPD is projected to be 14.5% in Australia, 4.4% to 16.7% in China, and 5.6% in Indonesia, while COPD (after removing asthmatics) was 8.6% in Japan, 13.4% in Korea, 4.7% in Malaysia, 5.4% to 6.1% in Taiwan, 3.7% to 6.8% in Thailand, 3.5% to 20.8% in the Philippines, and 6.7% in Vietnam, respectively. Thus, with the increasing prevalence of respiratory diseases, the demand for its monitoring is expected to increase, which is likely to propel the growth of the segment.

Furthermore, companies are developing advanced technologies, launching new products, and forming strategic alliances with the market players to stay competitive in the market. For instance, in November 2021, Cipla Limited launched Spirofy, India's first pneumotach based portable, wireless Spirometer, on World COPD Day. With this launch, the company intends to revolutionize Obstructive Airway Disease (OAD) diagnosis, in line with its ambition to strengthen its position as the lung leader in India. Such launches are expected to drive the segmental growth over the forecast period.

Thus, owing to the above factors, the spirometer segment is expected to show significant growth over the coming years.

North America is Expected to Dominate the Respiratory Monitoring Market Over the Forecast Period

North America has dominated the respiratory monitoring market, and the dominance of the market is mainly attributable to the increasing prevalence of respiratory diseases. Also, there is a rise in per capita health expenditure in the country, which is expected to increase over the forecast period owing to the decrease in the unemployment rate. According to data from the Asthma and Allergy Foundation of America, in April 2021, over 20 million people in the United States aged 18 and above suffer from asthma each year. Thus, the frequency of such conditions in the country implies a steady need for respiratory devices, causing the market under study in the United States to grow. In addition, according to the study published in Pulmonary Therapy in July 2022, the most common respiratory symptom, followed by a productive cough and shortness of breath, affects 17% of adult Americans. Thus, with the growing burden of respiratory diseases, the demand for respiratory monitoring devices is expected to increase over the forecast period, thereby boosting the market's growth.

Additionally, the development of advanced technology by the market players in the region supports market expansion. For instance, in March 2022, Respira Labs, a respiratory healthcare tech business based in the United States, released Sylvee, an AI-powered wearable lung monitor that employs acoustic resonance to assess lung function and identify variations in lung air volume. It aided in the early detection and treatment of chronic obstructive pulmonary disease (COPD), asthma, and COVID-19. Additionally, in March 2022, Respiri, a respiratory health management company, started its first reimbursed remote patient monitoring (RPM) pilot program at the Children's Hospital of Michigan in the United States. Such initiatives by the market players are expected to boost market growth over the forecast period.

Respiratory Monitoring Market Competitor Analysis

The respiratory monitoring market is moderate due to the presence of companies operating globally as well as regionally. The competitive landscape includes an analysis of international as well as local companies which hold significant market shares and are well known including Airsep Corporation, Medtronic (Covidien), Draegerwerk, GE Healthcare, Getinge Inc., Philips Healthcare, Resmed, Siemens Healthcare, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in the Number of Respiratory Diseases
    • 4.2.2 High Prevalence of Tobacco Smoking
    • 4.2.3 Development of Advanced Technologies
  • 4.3 Market Restraints
    • 4.3.1 Reimbursement Concerns
    • 4.3.2 High Price of the Monitoring Devices
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Type of Device
    • 5.1.1 Spirometers
    • 5.1.2 Peak Flow Meters
    • 5.1.3 Sleep Test Devices
    • 5.1.4 Gas Analyzers
    • 5.1.5 Pulse Oximeters
    • 5.1.6 Capnographs
    • 5.1.7 Other Types of Devices
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 United States
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 United Kingdom
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia-Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle East
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle East
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Airsep Corporation
    • 6.1.2 Medtronic (Covidien)
    • 6.1.3 Draegerwerk
    • 6.1.4 GE Healthcare
    • 6.1.5 Hamilton Medical
    • 6.1.6 Getinge Inc.
    • 6.1.7 Philips Healthcare
    • 6.1.8 Resmed
    • 6.1.9 Siemens Healthcare
    • 6.1.10 Vyaire Medical, Inc.
    • 6.1.11 Nihon Kohden Corporation
    • 6.1.12 Smiths Medical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS